Beta Bionics
(NASDAQ) BBNX
Beta Bionics Financials at a Glance
Market Cap
$757.55M
Revenue (TTM)
$110.24M
Net Income (TTM)
-$66.44M
EPS (TTM)
-$1.51
P/E Ratio
-11.25
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$17.07
Volume
0
Open
$16.89
Price
$17.07
Volume
0
Open
$16.89
Previous Close
$17.07
Daily Range
$16.69 - $17.17
52-Week Range
$8.80 - $32.71
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$17.07
Volume
0
Open
$16.89
Previous Close
$17.07
Daily Range
$16.69 - $17.17
52-Week Range
$8.80 - $32.71
Estimated Earnings Date
Aug 4, 2026
BBNX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Beta Bionics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
423
CEO
Sean Thomas Saint
Website
www.betabionics.comHeadquarters
Irvine, CA 92618, US
BBNX Financials
Key Financial Metrics (TTM)
Gross Margin
57.15%
Operating Margin
-70.13%
Net Income Margin
-60.27%
Return on Equity
-23.00%
Return on Capital
-24.31%
Return on Assets
-21.82%
Earnings Yield
-8.89%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$757.55M
Shares Outstanding
44.56M
Volume
0
Avg. Volume
1.01M
Financials (TTM)
Gross Profit
$63.00M
Operating Income
-$77.31M
EBITDA
-$63.50M
Operating Cash Flow
-$54.78M
Capital Expenditure
-$6.34M
Free Cash Flow
-$61.12M
Cash & ST Invst.
$199.52M
Total Debt
$6.91M
Beta Bionics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$27.63M
+56.6%
Gross Profit
$16.44M
+83.2%
Gross Margin
59.50%
N/A
Market Cap
$757.55M
N/A
Market Cap/Employee
$2.15M
N/A
Employees
352
N/A
Net Income
-$21.90M
+23.6%
EBITDA
-$21.22M
+24.3%
Quarterly Fundamentals
Total Cash
$199.52M
-13.8%
Total Debt
$6.91M
-0.9%
Accounts Receivable
$17.89M
+62.4%
Inventory
$23.73M
+50.8%
Long Term Debt
$5.07M
-6.9%
Short Term Debt
$1.84M
+20.7%
Return on Assets
-21.82%
N/A
Return on Invested Capital
-27.49%
N/A
Free Cash Flow
-$25.21M
-24.1%
Operating Cash Flow
-$23.83M
-19.3%